Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cortical and subcortical diseases: do true neuropsychological differences exist?

Juan Carlos Arango-Lasprilla1, Heather Rogers, Jean Lengenfelder

  • 1Neuropsychology and Neuroscience Laboratory, Kessler Medical Rehabilitation Research and Education Corporation, 300 Execute Drive, Suite 010 West Orange, NJ 07052, USA. jcarango@kmrrec.org

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists
|September 7, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026
Same author

Longevity and cognitive resilience in a Colombian family carrying the <i>APOE</i> ε2 variant.

Journal of Alzheimer's disease : JAD·2026
Same author

Source-space EEG alpha activity reveals brain age gaps due to neurodegeneration and disparity.

Communications biology·2026
Same author

Diversity-sensitive brain clocks linked to biophysical mechanisms in aging and dementia.

Nature. Mental health·2026
Same author

Comprehensive methodology for sample enrichment in EEG biomarker studies for Alzheimer's risk classification.

PloS one·2026
Same author

Blood-based AT(N) biomarkers for Alzheimer's disease and frontotemporal lobar degeneration in Latin America.

Nature aging·2026

This study found that genetically confirmed Familial Alzheimer's disease (FAD) and Huntington's disease (HD) patients show similar cognitive patterns, suggesting the cortical-subcortical distinction may not be clinically meaningful for these neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Genetics

Background:

  • Distinguishing cognitive patterns in cortical vs. subcortical diseases often lacks genetic confirmation and comprehensive cognitive assessment.
  • Previous studies have not exclusively used genetically confirmed patient groups for evaluating cognitive distinctions.

Purpose of the Study:

  • To investigate the cognitive differences between genetically confirmed Familial Alzheimer's disease (FAD) and Huntington's disease (HD) patients.
  • To determine if a comprehensive neuropsychological battery can differentiate between cortical and subcortical neurodegenerative disease patterns.

Main Methods:

  • Compared 10 FAD patients, 11 HD patients, and 17 healthy controls using a comprehensive neuropsychological battery.
  • Assessed cognitive functions including language, memory, attention, visual-spatial skills, and executive function.

Related Experiment Videos

  • Utilized genetically confirmed patient cohorts for precise group identification.

    • Main Results:

    • Animal Fluency and Letter Fluency were the only measures differentiating FAD and HD patients.
    • The neuropsychological battery distinguished between patients and healthy individuals but not between the two disease groups.
    • FAD and HD exhibited similar neuropsychological profiles.

    Conclusions:

    • The cortical versus subcortical cognitive distinction may not be clinically meaningful for differentiating FAD and HD.
    • Genetically confirmed FAD and HD present with overlapping cognitive deficits, challenging traditional disease categorization based on affected brain region.
    • Future research should explore alternative frameworks for understanding cognitive impairments in these diseases.